{
    "Trade/Device Name(s)": [
        "Hemoglobin A1c Assayed Control"
    ],
    "Submitter Information": "Compass Bioscience",
    "510(k) Number": "K060570",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "April 13, 2006",
    "Summary Letter Received Date": "March 7, 2006",
    "Submission Date": "February 28, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Compass Bioscience Hemoglobin A1c Assayed Control as a quality control material for HbA1c laboratory assay procedures",
    "Indications for Use Summary": "For use as a quality control material to assess the accuracy and precision of laboratory test methods measuring Hemoglobin A1c in patient samples",
    "fda_folder": "Clinical Chemistry"
}